Veradigm Inc. (NASDAQ:MDRX - Get Free Report) traded up 11% on Friday . The stock traded as high as $9.99 and last traded at $9.99. 89,232 shares changed hands during trading, a decline of 95% from the average session volume of 1,671,841 shares. The stock had previously closed at $9.00.
Wall Street Analyst Weigh In
Separately, StockNews.com initiated coverage on Veradigm in a research report on Thursday. They issued a "hold" rating for the company. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $12.00.
View Our Latest Report on MDRX
Veradigm Trading Up 2.8 %
The stock has a 50 day moving average of $9.54 and a 200-day moving average of $9.10.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the stock. Goldman Sachs Group Inc. increased its position in shares of Veradigm by 6.6% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,596,684 shares of the software maker's stock worth $16,749,000 after acquiring an additional 99,528 shares during the period. Vanguard Group Inc. increased its stake in shares of Veradigm by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker's stock valued at $149,754,000 after buying an additional 95,291 shares during the period. Innealta Capital LLC bought a new stake in shares of Veradigm in the second quarter valued at about $38,000. Tyro Capital Management LLC purchased a new stake in Veradigm in the first quarter worth about $9,055,000. Finally, Meadow Creek Wealth Advisors LLC bought a new position in Veradigm during the 1st quarter worth about $83,000.
About Veradigm
(
Get Free Report)
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
Before you consider Veradigm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.
While Veradigm currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
